| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/03/2002 | US6444468 Treating a sample comprising different double-stranded template polynucleotides wherein said different template polynucleotides contain areas of identity and areas of heterology under conditions which provide for the cleavage of |
| 09/03/2002 | US6444466 Antisense modulation of helicase-moi expression |
| 09/03/2002 | US6444465 Antinsense modulation of Her-1 expression |
| 09/03/2002 | US6444464 Antisense modulation of E2F transcription factor 2 expression |
| 09/03/2002 | US6444463 Neurogenic differentiation gene neurod3 and methods for inducing differentiation of cells |
| 09/03/2002 | US6444455 Stimulate phosphorylation and activation of substrates such as atf2, are provided. the polypeptides may be used, to identify antibodies |
| 09/03/2002 | US6444446 Calcium binding proteolipid compositions and methods |
| 09/03/2002 | US6444443 Gene |
| 09/03/2002 | US6444441 Production of human mutated proteins in human cells by means of homologous recombination |
| 09/03/2002 | US6444440 Vanilloid receptor-2 |
| 09/03/2002 | US6444439 Cloning and characterization of a cdc15-like adaptor protein (CD2BP1) |
| 09/03/2002 | US6444431 Angiostatin receptor |
| 09/03/2002 | US6444430 Ndr2-related proteins |
| 09/03/2002 | US6444425 Compositions may comprise one or more lung tumor proteins, immunogenic portions thereof, or polynucleotides that encode such portions. alternatively, a therapeutic composition may comprise an antigen presenting cell that expresses a lung |
| 09/03/2002 | US6444420 Use of GPR30 receptor ligands to mediate neurotrophic action |
| 09/03/2002 | US6444228 Autologous fibrin sealant and method for making the same |
| 09/03/2002 | US6444226 Purification and stabilization of peptide and protein pharmaceutical agents |
| 09/03/2002 | US6444223 Fineness particle size; sustained release of drug |
| 09/03/2002 | US6444220 Topical applying |
| 09/03/2002 | US6444208 Ribonuclease III from Streptococcus pneumoniae |
| 09/03/2002 | US6444207 Binding with epitope of antigen; anticancer agents |
| 09/03/2002 | US6444205 Transplantation of neural cells for the treatment of chronic pain or spasticity |
| 09/03/2002 | US6444202 Genetic engineering; immunsuppressants |
| 09/03/2002 | US6444201 Therapy for nervous system disorders |
| 09/03/2002 | US6444200 Interferon and one fatty acid moiety covalently attached to the cytokine that enhances cutaneous delivery; treating infections or enhancing an immune response |
| 09/03/2002 | CA2232985C Methods for treating cancers and restenosis with p21 |
| 09/03/2002 | CA2223566C Method for identifying or isolating a molecule and molecules identified thereby |
| 09/03/2002 | CA2178085C Glutaramide derivatives |
| 09/03/2002 | CA2160764C Fish pancreatic disease virus |
| 09/03/2002 | CA2105673C Method for production of a vegetable protein hydrolyzate and a use thereof |
| 09/03/2002 | CA2079778C Inhibitors of thrombin |
| 09/03/2002 | CA2001815C Products and methods for controlling the suppression of the neoplastic phenotype |
| 09/03/2002 | CA1341387C Human manganese superoxide dismutase (hmn-sod) |
| 09/02/2002 | CA2335411A1 Medical devices for modulation of apoptosis and immune response |
| 09/01/2002 | CA2356201A1 Compounds and compositions for delivering active agents |
| 08/29/2002 | WO2002066989A2 Diagnostics, assay methods and amelioration of muscular dystrophy symptoms |
| 08/29/2002 | WO2002066980A1 Methods for immuno-detection of epitopes on molecules and for detection of interactions of molecules via fluorescent dyes |
| 08/29/2002 | WO2002066681A2 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors |
| 08/29/2002 | WO2002066668A2 Method for producing proteins by fermentation of microorganisms from the thermus family, the protein mixture thus obtained and cosmetic compositions containing same |
| 08/29/2002 | WO2002066654A2 Drug metabolizing enzymes |
| 08/29/2002 | WO2002066650A2 Streptococcus pyogenes polypeptides and corresponding dna fragments |
| 08/29/2002 | WO2002066648A2 Immunoglobulin superfamily variants expressed in mesenchymal cells and therapeutic uses thereof |
| 08/29/2002 | WO2002066647A2 Type 2 ctokine receptor and nucleic acids encoding same |
| 08/29/2002 | WO2002066646A2 Neurotransmission-associated proteins |
| 08/29/2002 | WO2002066645A2 Mutant pro-neurotrophin with improved activity |
| 08/29/2002 | WO2002066642A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 08/29/2002 | WO2002066640A2 Zinc finger binding domains for nucleotide sequence ann |
| 08/29/2002 | WO2002066636A2 T cell receptor variants expressed in mesenchymal cells and uses thereof |
| 08/29/2002 | WO2002066626A2 Regulation of human mut/nudix nucleoside triphosphate pyrophosphohydrolase |
| 08/29/2002 | WO2002066623A2 Regulation of human phosphatidic acid-preferring phospholipase a1 |
| 08/29/2002 | WO2002066620A2 Pigmentary epithelium cell of the eye, the production thereof and the use of the same for treating diseases of the eye or of the central nervous system |
| 08/29/2002 | WO2002066609A2 23565, a novel human zinc carboxypeptidase family member and uses thereof |
| 08/29/2002 | WO2002066608A2 Virus derived antimicrobial peptides |
| 08/29/2002 | WO2002066601A2 Polynucleotide encoding a novel human potassium channel beta-subunit, k+betam2 |
| 08/29/2002 | WO2002066600A2 Methods and materials relating to leukocyte immunoglobulin receptor-like (lir-like) polypeptides and polynucleotides |
| 08/29/2002 | WO2002066516A2 Antibodies that bind both bcma and taci |
| 08/29/2002 | WO2002066514A2 Artificial fusion proteins with reduced immunogenicity |
| 08/29/2002 | WO2002066513A2 Human circulating lekti fragments hf7072, hf7638 and hf14448 and use thereof |
| 08/29/2002 | WO2002066512A1 Angiogenesis-inhibitory tripeptides, compositions and their methods of use |
| 08/29/2002 | WO2002066511A2 Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders |
| 08/29/2002 | WO2002066510A2 Regakine-1 |
| 08/29/2002 | WO2002066508A1 A novel traf6 inhibiting protein |
| 08/29/2002 | WO2002066505A2 Gmg-3, gmg-4, and gmg-6 polynucleotides and polypeptides and uses thereof |
| 08/29/2002 | WO2002066504A2 Protein-protein interactions in saccharomyces cerevisiae |
| 08/29/2002 | WO2002066502A1 Helicobacter pylori sialic acid binding adhesin, saba and saba - gene |
| 08/29/2002 | WO2002066500A2 ANTAGONISTS FPR Α4β7-INTEGRIN |
| 08/29/2002 | WO2002066499A1 Cyclic peptide |
| 08/29/2002 | WO2002066498A2 Peptide inhibiting platelet derived growth factor (pdgf-bb) and fibroblast growth factor (bfgf) activity |
| 08/29/2002 | WO2002066497A2 Tetrapeptide regulating prostate functions and its compositions and methods |
| 08/29/2002 | WO2002066494A2 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade |
| 08/29/2002 | WO2002066490A2 Cationic sterol derivatives, ph-sensitive liposomes comprising cationic sterol derivatives and method for loading liposomes with active substances |
| 08/29/2002 | WO2002066489A2 Amphoteric sterols and the use thereof in the production of ph-sensitive liposomes |
| 08/29/2002 | WO2002066488A1 Compositions and methods relating to prostate specific genes and proteins |
| 08/29/2002 | WO2002066421A1 Rgd-analog non-peptidic molecules having anti-adhesive, anti-migration and anti-proliferative effects |
| 08/29/2002 | WO2002066078A2 Modulated release particles for aerosol delivery |
| 08/29/2002 | WO2002066077A2 Modulated release particles for aerosol delivery |
| 08/29/2002 | WO2002066072A1 Methods for the treatment and diagnosis of prostate cancer based on p75ntr tumor |
| 08/29/2002 | WO2002066071A2 Treatment of tissue fibrosis by blocking the sp1 transcription factor |
| 08/29/2002 | WO2002066070A1 Pharmaceutical compositions containing decoy and method of using the same |
| 08/29/2002 | WO2002066069A1 Remedies for inflammatory/tumor diseases |
| 08/29/2002 | WO2002066068A2 Method of treating neurological diseases |
| 08/29/2002 | WO2002066067A2 Albumin-based drug delivery system and antimicrobial peptides |
| 08/29/2002 | WO2002066064A1 Use of galanin-like peptide |
| 08/29/2002 | WO2002066063A1 Remedies for metabolic bone diseases |
| 08/29/2002 | WO2002066062A2 Enhancement of glp-2 activity |
| 08/29/2002 | WO2002066058A1 Modified anti-egfr antibodies with reduced immunogenicity |
| 08/29/2002 | WO2002066052A1 Use of a conjugate of il-6 and an il-6 receptor in tumor therapy |
| 08/29/2002 | WO2002066051A1 Use of the g-csf as adjuvant treatment in connective tissue recontruction |
| 08/29/2002 | WO2002066050A1 Casoase 3 inhibitors |
| 08/29/2002 | WO2002066049A1 Agents for plasmic change |
| 08/29/2002 | WO2002066048A1 Crystal modification of a cyclic depsipeptide having improved strength |
| 08/29/2002 | WO2002066047A1 Use of $g(g)-gt inhibitors for the treatment of degenerative diseases |
| 08/29/2002 | WO2002066046A1 Cancer therapeutic agent comprising thiopeptide with multiple thiazole rings |
| 08/29/2002 | WO2002066045A2 Methods for modulating an immune response by modulating the interaction between ctla4 and pp2a |
| 08/29/2002 | WO2002066044A2 Method for dendritic cells based immunotherapy of tumors using combination therapy |
| 08/29/2002 | WO2002066043A2 Use of a polyfunctional active substance mixture as an antagonist against harmful substances contained in tobacco smoke |
| 08/29/2002 | WO2002066040A2 Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus |
| 08/29/2002 | WO2002066012A2 Amphoteric liposomes and the use thereof |
| 08/29/2002 | WO2002066010A1 Modulated release particles for aerosol delivery |
| 08/29/2002 | WO2002065992A2 A cell therapy method for the treatment of tumors |